Friday, 19 June 2020

Antiviral Drug Umifenovir Secures Nod for Clinical Trial for COVID-19: CSIR

Umifenovir is mainly used for treatment of influenza and is available in China and Russia, and has recently come into prominence due to its potential use for COVID-19 patients.


from Medindia Health News https://ift.tt/30Wa6sZ

No comments:

Post a Comment